#No.1 ISO 9001:2015 & GMP Certified Partner for PCD Pharma Franchise Company | Amcare Pharmaceuticals

Our Products

CEFIOFF(Tablets)

Product Composition

Cefixime 200 mg + Ofloxacin 200 mg

Packaging Details

10 X10 ALU-ALU

Product Description

CEFIOFF Tablets contain a potent combination of Cefixime 200 mg + Ofloxacin 200 mg, offering a broad-spectrum antibiotic solution for treating various bacterial infections. This dual-action formulation effectively targets a wide range of infections, ensuring faster recovery.

Usages of CEFIOFF Tablets

  • Treatment of respiratory tract infections such as pneumonia, bronchitis, and tonsillitis.
  • Effective against urinary tract infections (UTIs) and gynecological infections.
  • Prescribed for bacterial infections of the gastrointestinal tract, including typhoid and diarrhea.
  • Used in treating skin and soft tissue infections caused by bacterial pathogens.

Benefits of CEFIOFF Tablets

  • Dual antibiotic formulation enhances effectiveness against resistant bacterial strains.
  • Provides rapid relief from bacterial infections.
  • Oral tablet form ensures convenience and better patient compliance.
  • Well-tolerated under medical supervision with a strong safety profile.

Possible Side Effects of CEFIOFF Tablets

  • Gastrointestinal discomfort such as nausea, vomiting, or diarrhea.
  • Mild dizziness or headache in rare cases.
  • Potential allergic reactions like skin rash or itching.
  • Consult a healthcare provider if severe side effects occur.

Reliable PCD Pharma Manufacturer – Amcare Pharmaceuticals

Amcare Pharmaceuticals is a trusted manufacturer of Cefixime 200 mg + Ofloxacin 200 mg Tablets under the brand name CEFIOFF. We specialize in producing high-quality antibiotic formulations that comply with international pharmaceutical standards. As a leading player in the PCD Pharma franchise business, we provide excellent opportunities for distributors and medical professionals. Partner with us today to expand your business with premium pharmaceutical products. Contact us for more details.